<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Machine Learning Models for Predicting Smoking-Related Health Decline and Disease Risk - Health AI Hub</title>
    <meta name="description" content="This study systematically evaluated machine learning models for identifying early signs of smoking-related health decline, crucial for addressing the current is">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Machine Learning Models for Predicting Smoking-Related Health Decline and Disease Risk</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.14682v1" target="_blank">2511.14682v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-18
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Vaskar Chakma, MD Jaheid Hasan Nerab, Abdur Rouf, Abu Sayed, Hossem MD Saim, Md. Nournabi Khan
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, cs.ET
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.14682v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.14682v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This study systematically evaluated machine learning models for identifying early signs of smoking-related health decline, crucial for addressing the current issue of late diagnoses. Utilizing health screening data from 55,691 individuals, the Random Forest model emerged as the most accurate (AUC 0.926), revealing specific biomarkers like blood pressure, triglycerides, liver enzymes, and serum creatinine as strong indicators of health deterioration in smokers.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is critical for public health and preventive medicine by offering a data-driven approach to detect early physiological changes linked to smoking, potentially reducing preventable deaths and improving outcomes by enabling timely interventions before severe disease onset.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application involves using machine learning models (Random Forest, XGBoost, LightGBM) to classify current smoking status based on health screening biomarkers. This classification, as framed by the paper's overarching goal, serves as an early risk assessment tool to identify individuals at high risk for smoking-related health decline and disease. The models aim to support clinicians by providing an interpretable method to detect early warning signs often missed by traditional screening, enabling targeted interventions and improved patient outcomes.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Current medical screenings often miss early smoking-related health issues, leading to late-stage diagnoses.</li>
                    
                    <li>The study conducted a systematic comparative evaluation of machine learning models (Random Forest, XGBoost, LightGBM) for smoking-related health risk assessment.</li>
                    
                    <li>Health screening data from 55,691 individuals, including body measurements, blood tests, and demographic information, were analyzed.</li>
                    
                    <li>The study employed a cross-sectional design to classify current smoking status based on health screening biomarkers, rather than predicting future disease development.</li>
                    
                    <li>The Random Forest model demonstrated the best performance, achieving an Area Under the Curve (AUC) of 0.926, indicating high reliability in distinguishing risk levels.</li>
                    
                    <li>SHAP analysis identified blood pressure levels, triglyceride concentrations, liver enzyme readings, and kidney function indicators (serum creatinine) as the strongest predictive biomarkers for health decline in smokers.</li>
                    
                    <li>The research emphasizes clinical interpretability and practical deployment of ML models for early intervention.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study utilized a cross-sectional design, analyzing health screening data from 55,691 individuals, including body measurements, blood tests, and demographic information. Three advanced machine learning algorithms‚ÄîRandom Forest, XGBoost, and LightGBM‚Äîwere comparatively evaluated to classify current smoking status based on these biomarkers. Model performance was assessed using Area Under the Curve (AUC), and SHapley Additive exPlanations (SHAP) was employed for model interpretability.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The Random Forest model achieved the highest predictive accuracy with an AUC of 0.926. SHAP analysis revealed that blood pressure levels, triglyceride concentrations, liver enzyme readings, and serum creatinine were the most significant biomarkers for identifying smoking-related health decline.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The findings suggest a potential for developing more effective, early-stage screening tools for smoking-related health issues, enabling clinicians to identify at-risk individuals sooner. This could facilitate targeted interventions, lifestyle modifications, and smoking cessation programs, thereby preventing progression to late-stage diseases and improving patient outcomes.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The study employed a cross-sectional design, classifying current smoking status based on existing biomarkers rather than predicting future disease development. This means it identifies current health status correlates with smoking but does not forecast the onset of specific diseases.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly stated in the abstract, the noted limitation implies that future research could involve longitudinal studies to leverage these ML models for predicting the actual future development and progression of smoking-related diseases, and to validate the models in diverse populations.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Preventive Medicine</span>
                    
                    <span class="tag">Public Health</span>
                    
                    <span class="tag">Cardiology</span>
                    
                    <span class="tag">Nephrology</span>
                    
                    <span class="tag">Hepatology</span>
                    
                    <span class="tag">Endocrinology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">smoking</span>
                    
                    <span class="tag tag-keyword">machine learning</span>
                    
                    <span class="tag tag-keyword">health decline</span>
                    
                    <span class="tag tag-keyword">biomarkers</span>
                    
                    <span class="tag tag-keyword">Random Forest</span>
                    
                    <span class="tag tag-keyword">SHAP analysis</span>
                    
                    <span class="tag tag-keyword">early detection</span>
                    
                    <span class="tag tag-keyword">disease risk</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Smoking continues to be a major preventable cause of death worldwide, affecting millions through damage to the heart, metabolism, liver, and kidneys. However, current medical screening methods often miss the early warning signs of smoking-related health problems, leading to late-stage diagnoses when treatment options become limited. This study presents a systematic comparative evaluation of machine learning approaches for smoking-related health risk assessment, emphasizing clinical interpretability and practical deployment over algorithmic innovation. We analyzed health screening data from 55,691 individuals, examining various health indicators, including body measurements, blood tests, and demographic information. We tested three advanced prediction algorithms - Random Forest, XGBoost, and LightGBM - to determine which could most accurately identify people at high risk. This study employed a cross-sectional design to classify current smoking status based on health screening biomarkers, not to predict future disease development. Our Random Forest model performed best, achieving an Area Under the Curve (AUC) of 0.926, meaning it could reliably distinguish between high-risk and lower-risk individuals. Using SHAP (SHapley Additive exPlanations) analysis to understand what the model was detecting, we found that key health markers played crucial roles in prediction: blood pressure levels, triglyceride concentrations, liver enzyme readings, and kidney function indicators (serum creatinine) were the strongest signals of declining health in smokers.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>This paper has been officially accepted for publication in the Journal of Intelligent Medicine and Healthcare. Once the final published version is available online, this document will be updated accordingly</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>